Table 1.

Socio-demographic data of inflammatory bowel disease (IBD) patients and controls.

	Control Group	IBD Patients
Subjects, n (%)	32 Sigmoid cancer 11 (34.4%) Ascending colon cancer 4 (12.5%) Hepatic flex. cancer 2 (6.3%) Splenic flex. cancer 1 (3.1%) Caecal cancer 1 (3.1%) Rectal cancer 5 (15.6%) Diverticulosis 2 (6.3%) Sigmoid fistula 1 (3.1%) Ileus 3 (9.4%) Colon reconstruction 2 (6.3%)	31 CD 18 (58.1%) UC 13 (41.9%)
Sex
Men, n (%)	13 (40.6%)	17 (54.8%)
Women, n (%)	19 (59.4%)	14 (45.2%)
Age, year	62.28 ± 16.22	38.87 ± 12.64
BMI, kg/m2	24.45 ± 4.05	22.20 ± 4.33

Abbreviations: BMI: Body mass index; CD: Crohn’s disease; UC: Ulcerative colitis.